Nature, Published online: 12 November 2026; doi:10.1038/d41586-026-03684-x
Researchers are debating whether small, AI-enabled biotech companies are the future of drug discovery. Plus, even microplastics still reach the wildlife furthest from humanity and an upgrade to AlphaGenome.AI & ML
Daily briefing: Are one-person firms the future of biotech?
Nature News0 views
Source:https://www.nature.com/articles/d41586-026-03684-x
PreviousIs the sixth great extinction imminent? Scientists must draw on natural history for cluesNextThe secret to building Moon bases may be hiding in emergency blankets
Related posts
Questions swirl around FAA's new SMART AI system, though officials say no link to ground stop
0Phys.org Tech
Hong Kong rolls out AI facial recognition across CCTV network
0Phys.org Tech
Amazon loses 40 satellites in failed rocket launch
0Phys.org Tech
Purism Aiming To Deliver New Librem 5 Smartphone With RISC-V SoC
0Phoronix

Nvidia amassed $530 billion in financial guarantees to corner the AI market — supply commitments rose by nearly a quarter of a trillion dollars in a single quarter
0Tom's Hardware

Senator slams Commerce Secretary for flow of Nvidia AI chips to China
0The Verge